Konan, Japan

Yoshiaki Yamaji

This inventor holds 1 USPTO granted patent. Top assignee: Zeria Pharmaceutical Co., Ltd.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshiaki Yamaji. Retrieved from https://idiyas.com/inventor/yoshiaki-yamaji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoshiaki Yamaji: Innovator in Pharmaceutical Chemistry

Introduction

Yoshiaki Yamaji is a notable inventor based in Konan, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work has led to advancements in therapeutic agents that can impact various medical conditions.

Latest Patents

Yamaji holds a patent for an "Indan derivative and thromboxane antagonist containing the same." This invention showcases his expertise in creating compounds that can potentially serve as effective treatments in the pharmaceutical industry. He has 1 patent to his name, reflecting his innovative contributions to science.

Career Highlights

Yamaji is associated with Zeria Pharmaceutical Co., Ltd., a company known for its commitment to research and development in pharmaceuticals. His role at Zeria has allowed him to work on cutting-edge projects that aim to improve health outcomes for patients.

Collaborations

Throughout his career, Yamaji has collaborated with esteemed colleagues such as Kiyoshi Yoshida and Tadashi Kurimoto. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Yoshiaki Yamaji's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His patent and collaborations highlight the importance of teamwork in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…